To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Crime and Law Enforcement119-hr679 — To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.. Sponsored by Rep. Harshbarger, Diana [R-TN-1]. Introduced 2025-01-23. House bill. 119th Congress. Latest action: Referred to the House Committee on Energy and Commerce.
- Sponsor
- Rep. Harshbarger, Diana [R-TN-1] (R), TN
- Introduced
- 2025-01-23
- Committees
- Energy and Commerce Committee
- Subjects
- Abortion; Drug safety, medical device, and laboratory regulation; Drug therapy; Prescription drugs
- Latest Action
- Referred to the House Committee on Energy and Commerce.
No roll-call vote data available for this bill.
Similar Bills
- 116-hr3820 — Effective Drug Control Strategy Act 89% match 116th Congress
- 115-s1123 — Office of National Drug Control Policy Reauthorization Act of 2017 36% match 115th Congress
- 115-s3380 — A bill to direct the Office of National Drug Control Policy to track and review federally funded drug demand reduction activities. 33% match 115th Congress
- 118-hr8323 — Comprehensive Addiction Resources Emergency Act of 2024 31% match 118th Congress
- 118-hr2073 — To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Other Federal Drug Control Programs for fiscal year 2024. 30% match 118th Congress
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis